$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-031/19
  • A61K-031/205
출원번호 US-0346687 (1989-05-03)
발명자 / 주소
  • Cho Wing-Kee P. (Princeton NJ) Vadino Winston A. (Whitehouse Station NJ) Chaudry Imtiaz A. (Denville NJ)
출원인 / 주소
  • Schering Corporation (Kenilworth NJ 02)
인용정보 피인용 횟수 : 55  인용 특허 : 0

초록

Pharmaceutical compositions for use in the treatment of cough/cold symptoms comprising loratadine, ibuprofen and pseudoephedrine are disclosed.

대표청구항

A sustained release pharmaceutical composition comprising a coated tablet wherein the tablet coating comprises an antihistaminic-effective amount of loratadine or 6-chloro-6,11-dihydro-11-(4-piperidylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine and a hydrophilic polymer and the tablet core comprise

이 특허를 인용한 특허 (55)

  1. Kou Jim H., 8-chloro-6,11-dihydro-11- ] (4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions.
  2. Kositprapa, Unchalee; Sriwongjanya, Mongkol, Antihistamine and decongestant system.
  3. Lin, Jing; Truong, Hung, Antihistamine formulations for soft capsule dosage forms.
  4. Aberg,A. K. Gunnar; McCullough,John R.; Smith,Emil R., Compositions of descarboethoxyloratadine.
  5. Berlin, Roger G., Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines.
  6. Yoo, Jaedeok; Kumar, Sandeep; Monkhouse, Donald C., Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same.
  7. Yoo, Jaedeok; Kumar, Sandeep; Monkhouse, Donald C., Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same.
  8. Cho, Wing Kee Philip, Extended release oral dosage composition.
  9. Cho, Wing-Kee Philip, Extended release oral dosage composition.
  10. Cho, Wing-Kee Philip, Extended release oral dosage composition.
  11. Cefali, Eugenio A.; Bova, David J., Intermediate release nicotinic acid compositions for treating hyperlipidemia.
  12. Cefali, Eugenio A., Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics.
  13. Hite, Michael; Federici, Cathy; Brunelle, Alan; Turner, Stephen, Method for providing modified release of ibuprofen.
  14. Hite, Michael; Federici, Cathy; Brunelle, Alan; Turner, Stephen, Method of forming a tablet.
  15. Bova David J., Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night.
  16. Fine, Jay S.; Parker, Eric McFee, Methods and therapeutic combinations for the treatment of demyelination.
  17. Davis,Harry R.; Kosoglou,Teddy; Picard,Gilles J.; Ress,Rudyard J.; Strony,John T.; Veltri,Enrico P., Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors.
  18. Davis,Harry R.; Ress,Rudyard J.; Strony,John T.; Veltri,Enrico P., Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors.
  19. Davis,Harry R., Methods and therapeutic combinations for the treatment of xanthoma using sterol absorption inhibitors.
  20. Cho, Wing Kee Philip, Methods for inhibiting sterol absorption.
  21. Cefali, Eugenio A.; Bova, David J., Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia.
  22. Aberg,A. K. Gunnar; McCullough,John R.; Smith,Emil R., Methods for treating urticaria using descarboethoxyloratadine.
  23. Hite, Michael; Federici, Cathy; Brunelle, Alan; Turner, Stephen, Modified release ibuprofen dosage form.
  24. Bova David J., Nicotinic acid compositions for treating hyperlipidemia and related methods therefor.
  25. Bova, David J, Nicotinic acid compositions for treating hyperlipidemia and related methods therefor.
  26. Phillips, Jeffrey O., Omeprazole solution and method for using same.
  27. Sriwongjanya,Mongkol; Weng,Timothy; Barman,David; Kositprapa,Unchalee, Once a day antihistamine and decongestant formulation.
  28. Herman Van De Venne BE; Jean-Pierre Martin BE, Pharmaceutical compositions for the treatment of rhinitis.
  29. Herman van de Venne BE; Jean-Pierre Martin BE, Pharmaceutical compositions for the treatment of rhinitis.
  30. Cho, Wing-Kee Philip, Pharmaceutical formulation.
  31. Moore,William D.; Fitzpatrick,Shaun; Seiler,Christian; Saklatvala,Robert; Petts,Catherine R., Pharmaceutical formulation.
  32. Sharma, Vinay K., Preparation of micron-size pharmaceutical particles by microfluidization.
  33. Jain Girish Kumar,INX ; Rampal Ashok,INX ; Sen Himadri,INX, Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine.
  34. Irwin Jack T. ; Shah Shirish A., Pseudoephedrine hydrochloride extended-release tablets.
  35. Gelotte Cathy Klech ; Hills Joanna F. ; Pendley ; II Charles E. ; Shah Manoj N., Rapidly absorbed liquid compositions.
  36. Gelotte,Cathy Klech; Hills,Joanna F.; Pendley, II,Charles E.; Shah,Manoj N., Rapidly absorbed liquid compositions.
  37. Kou, Jim H., Stable extended release oral dosage composition.
  38. Kou, Jim H., Stable extended release oral dosage composition.
  39. Cho,Wing Kee Philip, Sterol absorption inhibitor compositions.
  40. Burnett, Duane A.; Clader, John W., Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof.
  41. Burnett, Duane A.; Clader, John W.; Vaccaro, Wayne, Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof.
  42. Burnett,Duane A.; Clader,John W., Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof.
  43. Burnett,Duane A.; Clader,John W., Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof.
  44. Burnett,Duane A.; Clader,John W., Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof.
  45. Burnett,Duane A.; Clader,John W., Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof.
  46. Burnett,Duane A.; Clader,John W., Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof.
  47. Burnett,Duane A.; Clader,John W.; Vaccaro,Wayne, Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof.
  48. Burnett,Duane A.; Clader,John W.; Vaccaro,Wayne, Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof.
  49. Phillips,Jeffrey Owen, Substituted benzimidazole dosage forms and method of using same.
  50. Affrime,Melton B.; Banfield,Christopher R.; Gupta,Samir K.; Padhi,Desmond, Treating allergic and inflammatory conditions.
  51. Harris Alan G. ; Iezzoni Domenic G., Treating sleep disorders using desloratadine.
  52. Harris Alan G. ; Iezzoni Domenic G., Treating sleep disorders using desloratadine.
  53. Schachtel, Bernard P., Use of analgesic potentiating compounds to potentiate the analgesic properties of an analgesic compound.
  54. Schachtel, Bernard P., Use of analgesic potentiating compounds to potentiate the analgesic properties of an analgesic compound.
  55. Davis,Harry R., Use of substituted azetidinone compounds for the treatment of sitosterolemia.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로